Pharmaceutical & Clinical Pharmacy Research Group (PCPRG)

Keyphrases

1. Older People 100%
2. Realist Review 97%
3. People with Dementia 88%
4. Severe Mental Illness 85%
5. Virtual Clinical Trials 76%
6. Pharmacist 76%
7. Pharmacokinetics 73%
8. Living with 67%
9. Medication Use 67%
10. Medication Management 66%
11. Medication Adherence 63%
12. Community Pharmacy 58%
13. Program Theory 58%
14. Realist Synthesis 57%
15. Pediatric 57%
16. Attention Deficit Hyperactivity Disorder 56%
17. Primary Care 54%
18. Rapid Realist Review 50%
19. Orally Disintegrating Tablet 50%
20. Sleep Disturbance 50%
21. Prescription-only 47%
22. Over-the-counter 47%
23. Dementia 46%
24. Medicines Optimisation 45%
25. During Pregnancy 45%
26. Service Users 42%
27. Substance Misuse Services 41%
28. Mixed Methods Evaluation 40%
29. Z-drugs 40%
30. Antipsychotics 39%
31. Pharmacokinetic Modeling 39%
32. Plasma Concentration 38%
33. Drug Interactions 38%
34. MEDLINE 37%
35. Oxadiazole 37%
36. Precision Dosing 37%
37. Solid Oral Dosage Forms 37%
38. Treatment Services 37%
39. Behaviours That Challenge 37%
40. Mild Cognitive Impairment 37%
41. Dosage Forms 37%
42. Pharmacy 37%
43. Realist 37%
44. Mental Health 36%
45. Medication Misuse 34%
46. Non-pharmaceutical Interventions 33%
47. Confidence Interval 33%
48. Clinical Trials 32%
49. What Works 31%
50. Care Homes 31%
51. Community Pharmacists 31%
52. Prospero 30%
53. Antipsychotic-induced Weight Gain 30%
54. Cognitive Function 30%
55. Age-appropriate 30%
56. Clinical Pharmacist 30%
57. Medication-taking 29%
58. Cognitive Decline 29%
59. Lived Experience 29%
60. General Practice 29%
61. Population Groups 28%
62. Family Caregivers 28%
63. Realist Research 28%
64. ADHD Medication 28%
65. Challenging Behaviour 28%
66. Pharmacy Practice 27%
67. Initial Program Theory 27%
68. Context-mechanism-outcome Configurations 27%
69. Healthcare Professionals 27%
70. Antidepressants 27%
71. Response to COVID-19 27%
72. Physiologically-based Pharmacokinetic Model 26%
73. Older Population 26%
74. Swallowability 25%
75. Public Health Response 25%
76. Clinical Pharmacy Services 25%
77. Osteoporosis Treatment 25%
78. Supporting Patients 25%
79. Cancer Population 25%
80. Australia 25%
81. Metabolic Syndrome 25%
82. Mental Health Curriculum 25%
83. Mental Health First Aid 25%
84. Ciprofloxacin 25%
85. COVID-19 25%
86. Sexual Violence 25%
87. Rifampicin 25%
88. Incident Dementia 25%
89. People with Intellectual Disabilities 25%
90. Meta-analysis 25%
91. Acidic Amino Acid 25%
92. Pharmacist Attitudes 25%
93. Osteoporosis 25%
94. Amino Acids 25%
95. Cardiometabolic Risk 25%
96. Oral Solid Dosage Forms 25%
97. Primary Diagnosis 25%
98. 2(5H)-furanone 25%
99. Primary Care Management 25%
100. Amino 25%